Newly Revised Evidence-Based Clinical Practice Guideline for Optometry Is Available for Peer and Public Review

By Staff
Friday, September 30, 2022 12:21 AM ST. LOUIS—The American Optometric Association announced the second edition of the AOA’s evidence-based clinical practice guideline, Comprehensive Adult Eye and Vision Examination, is now available online for a 30-day public review period.

Nominations for Jobson's 2022 EyeVote Readers' Choice Awards Are Open

By Staff
Thursday, September 29, 2022 12:33 AM NEW YORK—Vision Monday and 20/20 Magazine are hosting the 14th annual EyeVote Readers' Choice Awards to identify the optical industry’s favorite products and companies this year. These two Jobson Medical Information publications are teaming up once again this fall to get readers’ opinions by asking optical retailers’ and ECPs to identify their favorite products in 22 distinct categories: optical frames, spectacle lenses, sunglasses, sustainable materials for frames, sustainable materials for sunglasses, Rx sun lenses, contact lenses, optical equipment for wholesale prescription labs, optical supplies, ECP/retail in-office lab equipment, diagnostic instruments, practice management software, EHR software, online ordering website, patient engagement systems, dispensing/measuring fitting systems, online and social media marketing services, PPE, contactless dispensing devices, virtual try-on tools, telehealth solution and Social Purpose missions.

FDA Approves Expanded Range of Johnson & Johnson Vision’s Acuvue Abiliti Overnight Lenses

By Staff
Thursday, September 29, 2022 12:27 AM JACKSONVILLE, Fla.—Johnson & Johnson Vision announced FDA approval of an expanded range of Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management, now up to 6.00 diopters (previously 4.00 diopters).

Visus Therapeutics Expands Ophthalmic Drug Development Portfolio With Acquisition of ViewPoint Therapeutics’ Assets

By Staff
Thursday, September 29, 2022 12:18 AM SEATTLE, Wash.—Visus Therapeutics, a clinical stage biopharmaceutical company focused on developing multi-targeted treatments for the eye, yesterday announced it has expanded its pipeline via the acquisition of all patents and other assets of ViewPoint Therapeutics. Terms of the transaction were not disclosed. Founded in 2014, ViewPoint discovered and developed alpha-crystallin aggregation inhibitors as investigational non-surgical treatments to correct protein misfolding in the lens. Protein misfolding reduces lens elasticity and clarity leading to presbyopia and cataract, the leading causes of visual disability worldwide. Alpha-crystallin aggregation inhibitors are intended to restore elasticity and lens clarity, potentially reversing presbyopia and cataracts without the need for surgery.

National Center for Children’s Vision and Eye Health at Prevent Blindness Names Dr. Donny W. Suh as Recipient of the Bonnie Strickland Champion for Children’s Vision Award

By Staff
Thursday, September 29, 2022 12:15 AM CHICAGO—The National Center for Children’s Vision and Eye Health at Prevent Blindness (NCCVEH) has announced the recipient of the eighth annual “Bonnie Strickland Champion for Children’s Vision Award” as Donny W. Suh, MD, FAAP, MBA, FACS, chief of Pediatric Ophthalmology and Strabismus, and professor, Department of Ophthalmology and Visual Science, Gavin Herbert Eye Institute, University of California, Irvine. The award will be formally presented at the NCCVEH Annual Meeting, to be held virtually, on Friday, Oct. 14, 2022.

EyeCare Partners Launches an Innovation Center With Goal of Improving Patient Outcomes and Enhancing Care

By Staff
Wednesday, September 28, 2022 12:24 AM ST. LOUIS—EyeCare Partners (ECP), a leading provider of clinically integrated eyecare, yesterday announced the launch of the EyeCare Partners Innovation Center with a mandate to improve the delivery and quality of eyecare and advance clinical eye health education. ECP described the Innovation Center as “an information and technology center of excellence” that will “unite the expertise of over 1,000 eyecare providers with data from E360+, EyeCare Partners’ proprietary data platform, to advance eyecare quality, research and education.

Santen and UBE Receive FDA Approval for Glaucoma Eye Drop

By Staff
Wednesday, September 28, 2022 12:15 AM EMERYVILLE, Calif. & UBE, Japan—Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), and UBE Corporation (UBE) announced on Monday that the U.S. Food and Drug Administration (FDA) has approved OMLONTI (omidenepag isopropyl ophthalmic solution) 0.002% eye drops for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.

Guide Dogs for the Blind and American Foundation for the Blind Release Research Study Findings

By Staff
Tuesday, September 27, 2022 12:24 AM SAN RAFAEL, Calif., and WASHINGTON, D.C.—Guide Dogs for the Blind (GDB) and the American Foundation for the Blind (AFB) have released the findings of The Role of Guide Dogs in 2022 and Beyond, a joint, two-year research study to examine the long-term outlook for guide dog use in the U.S. and Canada. Top findings for the first-of-its-kind study revealed a greatly expanded use of technology among travelers who are blind or visually impaired, and a shift to using rideshare services from public transit and walking.

CooperVision Specialty EyeCare Appoints Weiwen Chen to Lead Asia-Pacific Region Expansion

By Staff
Tuesday, September 27, 2022 12:18 AM SAN RAMON, Calif.—CooperVision Specialty EyeCare has named Weiwen Chen as business manager, Asia-Pacific. In this newly-created role, she will lead the organization’s rapid growth and category expansion across the region.

BostonSight Hosts 4th Annual Retreat for Cornea and Contact Lens Residents

By Staff
Tuesday, September 27, 2022 12:15 AM NEEDHAM, Mass.—BostonSight, a nonprofit eye health care organization that advances the treatment of diseased and damaged corneas and dry eyes, hosted their fourth annual FitAcademy Retreat for Residents at New England College of Optometry in Boston, Sept. 16-17, 2022.

Travel Yukon and EnChroma Help People With Colorblindness See the Northern Lights

By Staff
Monday, September 26, 2022 12:15 AM SAN FRANCISCO, Calif.—Travel Yukon, an arm of the Canadian province of Yukon’s department of tourism and culture, has collaborated with EnChroma, a leading producer of glasses for colorblindness and low vision, to make the showstopping northern lights more accessible than ever before for the colorblind.

LASIK Is More Cost Effective Than Some Other Forms of Vision Correction, a New Study Shows

By Staff
Friday, September 23, 2022 12:24 AM NEW YORK—U.S. consumers who require vision correction pay about $500 annually for eyeglasses, contact lenses, eye exams and insurance, compared with about $100 for those who have had LASIK surgery, according to a new study. The study, conducted by a consortium of ophthalmologists and optometrists known as MyVision.org, pointed out although glasses and contacts are game changers for people with “bad vision,” the annual costs of an eye exam, new eyeglass lenses, a year’s supply of contacts, and prescription sunglasses can add up to a considerable amount of money over the course of a person’s lifetime.

Prevent Blindness, and the Prevention of Blindness Society of Metropolitan Washington, Holds ‘World Sight Day’ Vision Screening and Educational Event

By Staff
Friday, September 23, 2022 12:15 AM WASHINGTON, D.C.—On Sept. 21, Prevent Blindness, and the Prevention of Blindness Society of Metropolitan Washington, held the first World Sight Day Vision Screening and Eye Health Educational Event at the U.S. Capitol Building in Washington, D.C.

Prevent Blindness Declares Second Annual Inflammatory Eye Disease Awareness Week as Sept. 26 – Oct. 2

By Staff
Wednesday, September 21, 2022 12:21 AM CHICAGO—Prevent Blindness, the nation’s leading eye health and safety nonprofit organization, has declared Sept. 26 – Oct. 2, 2022, as the second annual Inflammatory Eye Disease (IED) Awareness Week.

NORA Honors Four Doctors for Their Work in Neuro-Optometric Rehabilitation

By Staff
Tuesday, September 20, 2022 12:15 AM MONROE, N.J.—The Neuro-Optometric Rehabilitation Association, International, (NORA) recognized the following individuals last week at the NORA’s Annual Conference in Columbus, Ohio for their important contributions to NORA and the field of neuro-optometric rehabilitation. Derrick Tong, OD, FAAO, FCOVD, FNORA was recipient of the Advancement of Neuro-Optometric Rehabilitation Award in recognition of his contribution to advancing the field of Neuro-Optometric Rehabilitation. Dr. Tong has been practicing optometry since 1998 and received Fellowships from the American Academy of Optometry, the College of Optometrists in Vision Development, and the Neuro-Optometric Rehabilitation Association. For the last six years, he has served as chair of the NORA Fellowship Committee.